Cathepsin D concentration in tumor cytosols improves the accuracy of prognostic evaluation of primary breast cancer

被引：0
作者：
Ardavanis, A
Scorilas, A
Amanatidou, A
Gerakini, F
Missitzis, I
Garoufali, A
Pissakas, G
Pateras, C
Apostolikas, N
Rigatos, G
Yiotis, I
机构：
[1] ST SAVVAS CANC HOSP,HORMONAL RECEPTORS LAB,ATHENS 11522,GREECE
[2] ST SAVVAS CANC HOSP,BREAST CLIN,ATHENS 11522,GREECE
[3] ST SAVVAS CANC HOSP,RADIOTHERAPY DEPT 2,ATHENS 11522,GREECE
[4] ST SAVVAS CANC HOSP,PATHOL LAB,ATHENS 11522,GREECE
来源：
ANTICANCER RESEARCH | 1997年 / 17卷 / 2B期
关键词：
breast cancer; prognostic factors; cathepsin D;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
One hundred and seventy three women were followed-up for a median of 62 months after surgery for Stage I-III breast cancer: The concentration of cathepsin D (CD) in tumor cytosols was compared to the standard prognostic factors for the disease and related to relapse free and overall survival and type of relapse. Three groups were identified with different prognostic profile. High CD levels significantly shorten DFS ill both node-negative and node-positive patients; a correlation between high cathepsin D levels and locoregional relapse should also be noted. This marker should be included in the initial evaluation of breast cancer as an indicator of invasiveness.
引用
收藏
页码：1405 / 1409
页数：5
相关论文
共 50 条
  • [41] Cathepsin D in host stromal cells, but not in tumor cells, is associated with aggressive behavior in node-negative breast cancer
    Nadji, M
    Fresno, M
    Nassiri, M
    Conner, G
    Herrero, A
    Morales, AR
    HUMAN PATHOLOGY, 1996, 27 (09) : 890 - 895
  • [42] CATHEPSIN-D AND C-ERB-B-2 HAVE AN ADDITIVE PROGNOSTIC VALUE FOR BREAST-CANCER PATIENTS
    SCORILAS, A
    YOTIS, J
    GOURIOTIS, D
    KERAMOPOULOS, A
    AMPELA, K
    TRANGAS, T
    TALIERI, M
    ANTICANCER RESEARCH, 1993, 13 (5C) : 1895 - 1900
  • [43] RELATIONSHIP BETWEEN CATHEPSIN-D AND OTHER PATHOLOGICAL AND BIOLOGICAL PARAMETERS IN 1752 PATIENTS WITH PRIMARY BREAST-CANCER
    GION, M
    MIONE, R
    DITTADI, R
    ROMANELLI, M
    PAPPAGALLO, L
    CAPITANIO, G
    FRIEDE, U
    BARBAZZA, R
    VISONA, A
    DANTE, S
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (05) : 671 - 677
  • [44] Does primary tumor location have prognostic significance in operable breast cancer?
    Badwe, RA
    Thorat, MA
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (08): : 396 - 397
  • [45] STROMAL CELL CATHEPSIN-D EXPRESSION AND LONG-TERM SURVIVAL IN BREAST-CANCER
    JOENSUU, H
    TOIKKANEN, S
    ISOLA, J
    BRITISH JOURNAL OF CANCER, 1995, 71 (01) : 155 - 159
  • [46] Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer
    Losch, A
    Kohlberger, P
    Gitsch, G
    Kaider, A
    Breitenecker, G
    Kainz, C
    BRITISH JOURNAL OF CANCER, 1996, 73 (12) : 1525 - 1528
  • [47] Co-expression of thymidine kinase and cathepsin D in 200 primary breast carcinomas
    Greco, S
    Marsigliante, S
    Leo, G
    Storelli, C
    CANCER LETTERS, 2000, 160 (01) : 13 - 19
  • [48] Detecting cell types and densities in the tumor microenvironment improves prognostic risk assessment for breast cancer
    Liu, Pu
    Zhang, Xueli
    Wang, Wenwen
    Zhu, Yunping
    Xie, Yongfang
    Tai, Yanhong
    Ma, Jie
    BIOMOLECULES AND BIOMEDICINE, 2024, 25 (01): : 106 - 114
  • [49] Prognostic significance of Ki-67 index value at the primary breast tumor in recurrent breast cancer
    Nishimura, Reiki
    Osako, Tomofumi
    Nishiyama, Yasuyuki
    Tashima, Rumiko
    Nakano, Masahiro
    Fujisue, Mamiko
    Toyozumi, Yasuo
    Arima, Nobuyuki
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (06) : 1062 - 1068
  • [50] CATHEPSIN-D EXPRESSION IN PRIMARY BREAST CARCINOMAS COMPARISON OF IMMUNOHISTOCHEMICAL AND BIOCHEMICAL DETECTION
    GOHRING, UJ
    INGENHORST, A
    CROMBACH, G
    SCHARL, A
    PATHOLOGE, 1993, 14 (06): : 313 - 317
12345